| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT05950464 Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the… |
date change Primary completion pushed: 2026-04-30 -> 2027-06-30 |
| 2026-06-12 | NCT05950464 Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the… |
date change Completion pushed: 2026-04-30 -> 2027-06-30 |
| 2026-06-12 | NCT05372640 Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694… |
date change Primary completion pushed: 2026-06-01 -> 2027-06-07 |
| 2026-06-12 | NCT05372640 Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694… |
date change Completion pushed: 2026-06-01 -> 2027-06-07 |
| 2026-06-12 | NCT05803382 Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy… |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-12 | NCT05803382 Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy… |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT05607108 | A Study of ZEN003694 in People With Squamous Cell Lung Cancer | Squamous Cell Lung Cancer | Recruiting |
| NCT04986423 | ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic… | Metastatic Castration-Resistant Prostate Cancer | Recruiting |
| NCT05327010 | Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in… | Advanced Malignant Solid Neoplasm | Recruiting |
| Phase 1/2 | |||
| NCT05053971 | Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT05019716 | Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to… | Advanced NUT Carcinoma | Recruiting |
| NCT04145375 | Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While… | mCRPC | Enrolling by Invitation |
| Phase 1 | |||
| NCT05422794 | Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor… | Anatomic Stage III Breast Cancer AJCC v8 | Recruiting |
| NCT05372640 | Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694… | Anatomic Stage III Breast Cancer AJCC v8 | Recruiting |
| NCT05803382 | Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy… | Metastatic Colorectal Carcinoma | Recruiting |
| NCT05950464 | Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the… | Recurrent Endometrial Carcinoma | Recruiting |